| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |